Gilead Sciences hits a 52-week high buoyed by investor optimism. We believe there is still room for growth and recommend the ...

【适应症】 无肝硬化或无门脉高压证据的代偿性肝硬化的原发性胆汁性胆管炎 (PBC)，对于对 UDCA 反应不足的成人，与熊去氧胆酸 (UDCA) 联合使用，或作为无法耐受 UDCA 的成人的单一疗法。 最初每天一次 5 毫克；如果 3 个月后 ALP 和/或总胆红素下降幅度不大且耐受 ...

in combination with ursodeoxycholic acid (UDCA) in adults who have an inadequate response to UDCA alone, or as monotherapy in those unable to tolerate UDCA. Seladelpar (an orphan designated ...

So, assuming 2% growth, Gilead is slightly undervalued. In fact, Gilead appears valued for 0% growth. Actually, this may be a ...

In order to qualify for Intern It UP, the intern must fill out the application form, be in a post-secondary learning ...

That leaves patients with limited second-line options for treatment if they fail to respond to or cannot tolerate ursodeoxycholic acid (UDCA), the standard first-line therapy, according to the ...

Analysts have suggested that the market for drugs to treat UDCA-refractory PBC could be worth $1.5 billion or more per year. A sharp rise in measles cases in 2024 in Europe has led to widespread ...

在一些复杂的情况下，如胆囊炎症严重或存在解剖异常时，可能需要进行开放式胆囊切除术。这是一种更为传统的手术方式，需要在腹部做一个较大的切口来移除胆囊。由于其创伤较大，恢复时间较长，因此现在较少使用。